Jean‐Michel Scherrmann

7.4k total citations
114 papers, 5.0k citations indexed

About

Jean‐Michel Scherrmann is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Jean‐Michel Scherrmann has authored 114 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 31 papers in Pediatrics, Perinatology and Child Health and 28 papers in Molecular Biology. Recurrent topics in Jean‐Michel Scherrmann's work include Drug Transport and Resistance Mechanisms (63 papers), Pharmacological Effects and Toxicity Studies (29 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Jean‐Michel Scherrmann is often cited by papers focused on Drug Transport and Resistance Mechanisms (63 papers), Pharmacological Effects and Toxicity Studies (29 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Jean‐Michel Scherrmann collaborates with scholars based in France, United States and Canada. Jean‐Michel Scherrmann's co-authors include Xavier Declèves, Salvatore Cisternino, Françoise Hervé, Nicolae Ghinea, Christophe Rousselle, Elisabeth Niel, Fanchon Bourasset, Jamal Temsamani, Françoise Roux and Philippe Clair and has published in prestigious journals such as New England Journal of Medicine, Cancer Research and Scientific Reports.

In The Last Decade

Jean‐Michel Scherrmann

114 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Michel Scherrmann France 42 2.0k 1.6k 934 652 573 114 5.0k
Xavier Declèves France 39 1.8k 0.9× 1.1k 0.7× 905 1.0× 792 1.2× 540 0.9× 149 4.5k
Ken‐ichi Hosoya Japan 46 2.1k 1.0× 2.5k 1.5× 1.2k 1.3× 995 1.5× 900 1.6× 217 7.5k
Laurence Fénart France 39 1.4k 0.7× 1.9k 1.2× 356 0.4× 1.5k 2.3× 413 0.7× 64 5.1k
Larry Baum Hong Kong 38 689 0.3× 1.4k 0.9× 738 0.8× 347 0.5× 547 1.0× 135 5.4k
Jean‐François Ghersi‐Egea France 38 1.0k 0.5× 1.2k 0.8× 975 1.0× 1.1k 1.8× 947 1.7× 93 4.8k
Patrick T. Ronaldson United States 30 1.1k 0.5× 979 0.6× 445 0.5× 1.4k 2.2× 307 0.5× 57 3.4k
Salvatore Cisternino France 30 1.2k 0.6× 778 0.5× 660 0.7× 499 0.8× 389 0.7× 124 2.7k
María Alexandra Brito Portugal 42 594 0.3× 2.5k 1.5× 1.5k 1.6× 974 1.5× 315 0.5× 111 4.9k
Dora Brites Portugal 52 774 0.4× 3.9k 2.4× 2.5k 2.7× 1.8k 2.8× 524 0.9× 164 7.9k
Yoshimichi Sai Japan 49 4.3k 2.1× 2.9k 1.8× 2.1k 2.2× 161 0.2× 322 0.6× 185 8.6k

Countries citing papers authored by Jean‐Michel Scherrmann

Since Specialization
Citations

This map shows the geographic impact of Jean‐Michel Scherrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Scherrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Scherrmann more than expected).

Fields of papers citing papers by Jean‐Michel Scherrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Michel Scherrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Scherrmann. The network helps show where Jean‐Michel Scherrmann may publish in the future.

Co-authorship network of co-authors of Jean‐Michel Scherrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Scherrmann. A scholar is included among the top collaborators of Jean‐Michel Scherrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Scherrmann. Jean‐Michel Scherrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez-Zepeda, David, et al.. (2019). ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas. Pharmaceutics. 12(1). 20–20. 87 indexed citations
2.
Campagne, Olivia, Sylvain Fouliard, Marylore Chenel, et al.. (2018). Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity. Clinical Cancer Research. 24(11). 2631–2641. 41 indexed citations
3.
Gómez-Zepeda, David, Maria Smirnova, Wang‐Qing Liu, et al.. (2018). LC–MS/MS-based quantification of efflux transporter proteins at the BBB. Journal of Pharmaceutical and Biomedical Analysis. 164. 496–508. 18 indexed citations
4.
Hosten, Benoît, Raphaël Boisgard, Aude Jacob, et al.. (2013). [11C]befloxatone brain kinetics is not influenced by Bcrp function at the blood–brain barrier: A PET study using Bcrp TGEM knockout rats. European Journal of Pharmaceutical Sciences. 50(3-4). 520–525. 9 indexed citations
5.
Ball, Kathryn, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, & Xavier Declèves. (2012). Development of a Physiologically Based Pharmacokinetic Model for the Rat Central Nervous System and Determination of an In Vitro–In Vivo Scaling Methodology for the Blood–Brain Barrier Permeability of Two Transporter Substrates, Morphine and Oxycodone. Journal of Pharmaceutical Sciences. 101(11). 4277–4292. 44 indexed citations
6.
Saubaméa, Bruno, et al.. (2011). Heterogeneity in the Rat Brain Vasculature Revealed by Quantitative Confocal Analysis of Endothelial Barrier Antigen and P-Glycoprotein Expression. Journal of Cerebral Blood Flow & Metabolism. 32(1). 81–92. 54 indexed citations
7.
Declèves, Xavier, Aude Jacob, Salah Yousif, et al.. (2011). Interplay of Drug Metabolizing CYP450 Enzymes and ABC Transporters in the Blood-Brain Barrier. Current Drug Metabolism. 12(8). 732–741. 72 indexed citations
8.
Ait‐Oudhia, Sihem, Jean‐Michel Scherrmann, & Wojciech Krzyżański. (2010). Time‐dependent clearance and hematological pharmacodynamics upon erythropoietin multiple dosing in rats. Biopharmaceutics & Drug Disposition. 31(5-6). 298–315. 10 indexed citations
9.
Fonsart, Julien, Marie‐Claude Menet, Marcel Debray, et al.. (2009). Sprague–Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA). Toxicology and Applied Pharmacology. 241(3). 339–347. 25 indexed citations
10.
Fonsart, Julien, Marie‐Claude Menet, Xavier Declèves, et al.. (2008). Sprague–Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Toxicology and Applied Pharmacology. 230(1). 117–125. 28 indexed citations
11.
Hervé, Françoise, Nicolae Ghinea, & Jean‐Michel Scherrmann. (2008). CNS Delivery Via Adsorptive Transcytosis. The AAPS Journal. 10(3). 455–472. 470 indexed citations
12.
Niel, Elisabeth & Jean‐Michel Scherrmann. (2006). Colchicine today. Joint Bone Spine. 73(6). 672–678. 221 indexed citations
13.
Yousif, Salah, Cynthia Marie‐Claire, Françoise Roux, Jean‐Michel Scherrmann, & Xavier Declèves. (2006). Expression of drug transporters at the blood–brain barrier using an optimized isolated rat brain microvessel strategy. Brain Research. 1134(1). 1–11. 116 indexed citations
14.
Camenisch, Gian, et al.. (2006). Influence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain Barrier. Drug Metabolism and Disposition. 34(12). 1945–1949. 18 indexed citations
15.
Scherrmann, Jean‐Michel. (2005). Expression and function of multidrug resistance transporters at the blood–brain barriers. Expert Opinion on Drug Metabolism & Toxicology. 1(2). 233–246. 49 indexed citations
16.
Scherrmann, Jean‐Michel & Jamal Temsamani. (2005). The use of Pep: Trans vectors for the delivery of drugs into the central nervous system. International Congress Series. 1277. 199–211. 14 indexed citations
17.
Bourasset, Fanchon & Jean‐Michel Scherrmann. (2005). Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-β-d-glucuronide. Life Sciences. 78(20). 2302–2314. 21 indexed citations
18.
Temsamani, Jamal, Cécile Bonnafous, Christophe Rousselle, et al.. (2005). Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy. Journal of Pharmacology and Experimental Therapeutics. 313(2). 712–719. 26 indexed citations
19.
Mercier, Claire, Christophe Masseguin, Françoise Roux, Jacqueline Gabrion, & Jean‐Michel Scherrmann. (2004). Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes. Brain Research. 1021(1). 32–40. 73 indexed citations
20.
Chanez, C., et al.. (1991). Existence of a Digitalis-Like Compound in the Human Fetus. Neonatology. 59(3). 133–138. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026